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ABSTRACT Eurycoma longifolia has been widely recognized for its aphrodisiac benefits and many 
herbal products incorporated with its extract been sold worldwide. The products in various forms of 
capsules or spherical tablets were appropriately solubilized in water and their protein content were 
separated using two dimensional electrophoresis (IPG strip of pI 3-10; 15% homogenous gel) and stained in 
coomassie blue. In this study using a standardized extract known for its biological activity, CFPR-JV1, two 
distinctive protein markers were detected within 2DE gel. The markers were spots found approximately at 
molecular weight of 14kDa at the basic extremities. The markers were not detected in a selected herbal 
product devoid of Eurycoma longifolia extract. In screening markers on a total of 23 National 
Pharmaceutical Control Bureau (NPCN) approved and 6 NPCB un-approved products claimed to have 
included Eurycoma longifolia extracts gave results with 18 of the 29 (approximately 62%) products 
observed with the presence of at least marker A, while the rest did not show presence of any markers. This 
enabled authentication of the products tested related to its active constituent. It is expected that the protein 
markers in addition to the existing chemical marker, Eurycomanone, may serve to be useful in 
authenticating genuine, unadulterated or sufficiently enough amount of Eurycoma longifolia in herbal 
aphrodisiac products. 
 
ABSTRAK Tongkat Ali telah diiktiraf secara meluas bagi faedah perangsang seksualnya dan banyak 
produk-produk herba yang digabungkan dengan ekstrak herba ini telah dijual di seluruh dunia. Produk 
dalam bentuk kapsul atau tablet sfera yang pelbagai sesuai dilarutkan dalam air dan kandungan protein 
mereka telah dipisahkan menggunakan jel dua dimensi (jalur IPG pI 3-10; 15% jel homogenus) dan 
diwarna dengan coomassie biru. Dalam kajian ini suatu ekstrak yang sebelum ini telah diiktiraf 
mengandungi aktiviti biologi iaitu ekstrak CFPR-JV1 telah dikesani dengan dua penanda protein melalui 
teknik jel 2DE. Penanda-penanda berkenaan adalah pada lokasi kira-kira berat molekul 14kDa dan pada 
kawasan beralkali. Penanda-penanda protein ini tidak dikesan dalam produk herba yang diiktiraf tidak 
mempunyai ekstrak Tongkat Ali. Dalam saringan penanda di dalam sejumlah 23 produk kategori lulusan 
Biro Kawalan Farmaseutikal Kebangsaan (NPCN) serta 6 produk dalam kategori tidak pernah diluluskan 
oleh NPCN tetapi mendakwa menagandungi ekstrak Tongkat Ali memberi keputusan cerakinan iaitu 18 
daripada 29 (kira-kira 62%) produk dikesani dengan kehadiran sekurang-kurangnya dengan penanda A, 
manakala yang lain tidak menunjukkan kehadiran kedua-dua penanda. Pengesahan ini membolehkan 
produk-produk tersebut diujikesan dengan juzuk yang aktif. Oleh yang demikian adalah dijangkakan 
penanda protein selain penanda kimia yang sedia ada iaitu Eurycomanone, berguna dalam mengesahkan 
kesahihan kehadiran ekstrak Tongkat Ali dalam pelbagai produk herba afrodisiak. 
 
 (Keywords: plant, aphrodisiac, standardization, two dimensional electrophoresis, protein) 
 
INTRODUCTION 
 
Eurycoma longifolia from the family 
Simaroubaceae is a medium sized shrub that is 
endemic to Southeast Asia[1]. The locals 
identify it by the common name ‘Pasak Bumi’ or 
‘Tongkat Ali’ and it has been long recognized as 
an herbal plant with several medicinal values.  
 
The root extract is believed to be an aphrodisiac 
which enhance male virility and sexual prowess. 
The plant extract (particularly roots) have been 
used in indigenous traditional medicines for its 
unique antimalarial, anti-pyretic, antiulcer, 
cytotoxic and aphrodisiac properties [2-6]. The 
aphrodisiac property of E. longifolia was 
confirmed by various studies done on male rats 
[7-15].  
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The aphrodisiac power of E. longifolia has been 
harnessed and commercialized with estimates of 
nearly 200 products, mainly highlighting the 
aphrodisiac properties, are available in the 
health-food market [5]. Since it is widely 
acknowledged by people all around the world, 
the demand for E. longifolia supplements 
especially those in the form of capsules and 
tablets are hence, worldwide [16].  Extracts of 
this herb have often been incorporated in some 
natural body building supplements due to the 
positive effect of this plant on testosterone 
production. Recently, it has been effectively 
marketed as an aphrodisiac and a natural libido 
enhancer that can help many middle aged men to 
retrieve their youthful appetite [17]. The amount 
of extract used in each tablet is vital as low 
concentrations are ineffective. This can be 
overcome if the extraction and preparation 
processes are standardized, however this is not 
the case and therefore, it remains questionable 
whether every product still retain enough of the 
bioactive constituent of E. longifolia. This is 
especially true for products that are not approved 
by any pharmaceutical authoritative bodies. We 
suspect that these clandestine “cottage” 
industries which lack quality control might 
produce products that do not contain E. 
longifolia root extract at all or that the unsubtle 
processing methods might damage its 
pharmaceutical properties. Counterfeit drugs 
have recently become a serious problem all over 
the world where products are deliberately 
mislabeled, added with the wrong ingredient, 
wrong amount of ingredient or with no active 
ingredient at all [18].  
 
The Malaysian National Pharmaceutical Control 
Bureau (NPCB) requires for approval purposes 
all herbal product manufacturers to submit 
information that include the manufacturing 
process, material specifications, quality control 
of raw material and test data.  Even after that, the 
products are constantly under post marketing 
surveillance in which chemical tests are 
performed on random samples. Tests conducted 
by both manufacturers and NPCB include those 
that check its pharmaceutical content, heavy 
metal content (As, Pb, Cd and Hg), triterpenes 
and steroid content, weight uniformity and 
microbial contamination[19]. Despite the 
stringency, it remains elusive whether NPCB 
validate or has the mean to validate the 
aphrodisiac property of the products. Although a 
microcontroller-based taste system had been 
invented to discriminate between liquids that 
contain E. longifolia extract and those that are 
not, the invention detects various different 
chemical components of the liquid and not its 
bioactive aphrodisiac component. [20] Many 
unique organic molecules and quassinoids such 
as eurycomanone, eurycomanol, eurycomaoside 
etc have been identified [16, 21], but it has been 
determined that the aphrodisiac bioactive 
component of E. longifolia is a peptide that has 
been patented by the name Eurypeptide [22-23]. 
The results of an earlier research based on 
collaboration between MIT-FRIM linked the 
active components of E. longifolia to be protein 
based as well [24]. As such in this current study 
proteomics technology (conventional method for 
protein characterization) was used to investigate 
potential protein markers that can be used to 
authenticate some E. longifolia contained 
products in the market. 
 
MATERIAL AND METHODS 
 
Test materials 
 
E. longifolia capsules of different brands were 
obtained from various pharmacies and drug 
stores in peninsular Malaysia. Some products are 
sold online to international customers. These 
products are classified into two groups, those 
that are approved by NPCB (coded as MON-A01 
– MON-A23) and the others that are not (coded 
as MON-X01 – MON-X06). All approved 
products are attached with a NPCB hologram 
sticker while the unapproved ones are not. The 
name, brand and the manufacturer of the 
capsules are not shown to protect the anonymity 
of the products. For products that come in the 
form of capsules, the shells were physically 
removed and the powdery content was stored. 
For spherical tablets, they were crushed by using 
mortar and pestle until they became powdery. 
CFPR-JV1 and MON-JV1 were used as positive 
controls while MON-NC which contains Smilax 
myosotiflora extract instead of E. longifolia was 
used as negative control. CFPR-JV1 is a 
standardized E. longifolia root extract obtained 
from Forest Research Institute Malaysia (FRIM) 
while MON-JV1was extracted in our own 
laboratory. Its extraction is as follows, initially, 
50g of E. longifolia root chips were boiled with 
600ml of deionized distilled water in a round 
bottom flask attached to a condenser for 5 hours. 
Then, the condensed liquid was filtered before 
being freeze dried for the final powdery 
products. All MON-JV1 extracted samples were 
kept at -20°C. 
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Two Dimensional Gel Electrophoresis (2DE) 
 
The protein content in each sample was 
quantified by using Bradford protein 
quantification assay.  The first dimensional run; 
Isoelectric focusing (IEF) was then performed on 
rehydrated Immobiline™ Drystrip pH 3-10NL, 
7cm IPG strips (GE Healthcare) with the sample 
loaded by using a sample cup. Prior to this, the 
correct amount of sample with 25μg protein 
content was mixed with 250μl of rehydration 
buffer containing 8M urea, 2% (w/v) CHAPS, 
20mM DTT (dithiothereitol), 1% (v/v) IPG 
buffer and 0.002% (w/v) Bromophenol Blue. 
The order of parameters used during IEF run 
were step and hold at 200V for 1 hour, gradient 
at 1000V for 1 hour, gradient at 5000 for 4 hours 
and finally step and hold at 5000V for 1 hour. 
After IEF, the IPG strips were equilibrated twice 
on a rocking table with buffer containing 50mM 
Tris/HCl, 6M urea, 30% (v/v) glycerol, 2% SDS 
and a trace of Bromophenol Blue with addition 
of 30mM DTT for the first time and 70mM 
iodoacetamide for the second time, 10 minutes 
each. The second dimensional run; 
polyacrylamide gel electrophoresis (PAGE) was 
performed thereafter. The equilibrated strips 
were loaded onto a 15% polyacrylamide gel 
(9.6cm length X 8.2cm width) and the 
electrophoresis run was initiated at 250V until 
the dye front reached the bottom of the gel. The 
separated gel proteins were visualized by 
Coomassie Brilliant Blue staining. They were 
then scanned by a digital scanner and saved in 
tagged image file format (TIFF). 
 
Another modified 2DE run was also performed 
whereby MON-A07 was “spiked” with the 
positive control, CFPR-JV1. This was done by 
introducing the two samples separately using two 
loading cups onto a rehydrated IPG strip during 
IEF run as described in previous works [25-27]. 
 
Data analysis 
 
Scanned gel pictures were analyzed using Bio 
Rad’sPDQuest 2D Analysis Software. The image 
was automatically rendered into grayscales by 
the software in order for it to perform further 
analysis on the picture. The background noise 
was filtered out using Gaussian filtering method. 
Once filtered, the area expected to have the 
markers were analyzed using the software’s 3D 
viewer to confirm the marker’s peaks. 
 
RESULTS 
 
Markers and their validation  
 
In both positive controls, CFPRJV1 and MON-
JV1, two prominent and reproducible spots were 
detected approximately at molecular weight of 
14kDa (15% homogenous gel) at basic 
extremities of a 3-10 IPG strip [Fig. 1(a) and 
(b)]. The gels were only stained with coomassie 
blue as attempts to stain with silver staining 
method failed to show any spots (results not 
included). Negative control, MON-NC, though 
showed other spots but not the markers [Fig. 1 
(c)]. Figure 1 also showed two products been 
screened for presence of markers, A and B, with 
MON-A15 having them [Fig 1 (d)] while none 
observed in MON-A09 [Fig. 1(e)].    
 
Another validation method that was performed in 
this study was “spiking”. One of the samples was 
loaded separately with positive control, CFPR-
JV1 onto the same IPG strip. The amount of 
proteins loaded from each cup was 25μg. If the 
proteins of interest from the tested samples had 
similar charge and molecular size with the 
positive control, the two dimensionally separated 
protein markers should be more pronounced and 
slightly larger in size. Taking MON-A07 as a 
representative, its protein sample was spiked 
with positive control CFPR-JV1. After spiking, 
the markers are significantly more distinct. The 
3D representation shows visibly higher peaks for 
both the markers, thus validating them (Fig 2). 
Besides that, it also shows that spiking is a 
reliable method to confirm that protein spots 
from two different samples are of same protein 
origin. 
 
In a total of 23 NPCB approved samples that 
have been tested, 14 showed the presence of 
marker A while 13 for marker B (Table 1). 
MON-A06 was the only sample which showed 
the presence of marker A but not marker B. 
While for the six samples that were unapproved 
by NPCB only MON-X04 and MON-X06 were 
found to have none of the markers present. 
MON-A10 which showed a negative result for 
both markers was actually devoid of E. longifolia 
extract according to the ingredient description 
even though it is labeled as a ‘Tongkat Ali’ 
herbal product. Hence, a total of 14/23 (~61%) 
of the NPCB approved products in comparison 
to 4/6 (~67%) of the unapproved NPCB products 
showed the presence of marker A. Overall 
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approximately 62% of the total products showed presence of marker(s).  
 
 
Figure 1. 2DE on (a) CFPRJV1 (positive control), (b) MON-JV1 (positive control), (c) MON-NC 
(negative control), (d) MON-A15 (product with both markers detected) and (e) MON-A09 (product with no 
markers). Insert on upper right corner showing 3D view obtained using Bio Rad’s PDQuest.  
 
Figure 2. The stained gel images and the corresponding 3D representations of CFPR-JV1, MON-A07 and 
spiking of CFPR-JV1 with MON-A07. 
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Table 1. The presence (✓) or absence (✗) of protein markers A and B in each tested samples.  
 
No Sample Protein 
content 
(μg/mg 
sample) 
Product content (%) Marker 
A 
Marker 
B 
1 MON-A01 1.5162 100.0 EL ✗ ✗ 
2 
MON-A02 2.7439 
40.0 EL; 20 Tinospora cordifolia stem extract; 20.0 
Glycyrrhiza glabra root extract; 20.0 Centella asiatica 
herb extract 
✓ ✓ 
3 
MON-A03 3.1967 
8.6 EL; 17.2 Herbs Epimedium brevicornum; 17.2 
Actinolitum ; 17.2 Cuscuta chinensis; 17.2 Cynomorium 
songaricum; 13.8 Semen Cuscuta chinensis; 8.6 Herb 
Cistannche  deserticola 
✗ ✗ 
4 
MON-A04 8.1172 
68.1 EL; Semen 1.9 Pimpinella anisum; 4.2 Semen 
Cumimum cymimum; 1.9 Rhizome Zingiber officinale;  
1.9 Sticepus variegahus; 1.9 Sticepus variegahus; 1.9 
semen Piper nigrum; 1.9 Semen Piper nigrum; 1.2 Semen 
Coriandrum sativum; 4.0 Rhizoma Alpinia golango; 6.7 
Radix Curcuma zedoaria; 4.2 Garlic oil macerate. 
✓ ✓ 
5 MON-A05 2.1419 60.0 EL; 40.0 Radix Astragali seu hedysari. ✓ ✓ 
6 
MON-A06 5.6404 
15.6 EL; 21.9 Rhizoma Smilax  
myosotiflora; 15.6 Rhizoma Allomorphia malacensis; 4.7 
Semen Trigonella foenum graecum; 7.8 Rhizoma 
Zingiber minus; 7.8 Caulis Leptosmermum flavescens; 4.7 
Rhizoma Acorus calamus; 9.4 Semen Nigella sativa; 4.7 
Semen Coriandrum sativum; 4.7 Fructus Piper longum; 
3.1 Semen Trachyspermum ammi. 
✓ ✗ 
7 
MON-A07 5.2864 
85.0 EL; 10.0 Semen Nigella sativa; 5.0 Folium Cassia 
angustifolia. 
✓ ✓ 
8 
MON-A08 11.284 
24.0 EL; 20.0 Nigella sativa; 10.0 Globia Pendula; 2.0 
Curcuma domestica; 10.0 Piper nigri fructus; 10.0 
Languas galangal; 24.0 Foeniculum vulgare. 
✓ ✓ 
9 
MON-A09 4.4613 
20.0 EL; 40.0 Fructus Saw palmetto Power extract; 10.0 
Pumpkin Seed Powder Extract; 10.0 Fructus Tribulus 
terrestris powder extract; 20.0 Root Muria puama powder 
extract. 
✗ ✗ 
10 
MON-A10 4.3800 
0.0 EL, 21.5 Herbs Coriondrum sativum; 4.4 Radix 
Smilax myositiflora; 4.3 Herb Pimpenella anisum; 4.3 
Herbs Cuminum cyminum; 4.3 Seed Nigella sativa; 4.3 
Rizom Alpinia galanga; 3.2 Rizom Curcuma domestica; 
33.4 Honey; 3.1 Sesame oil; 3.2 Rizom Zingeber 
officinale; 4.3 Flos Eugenia aromatica; 2.2 Helicteres 
isora; 2.2 Fructus Myristica fragrans; 2.2 Seed Piper 
nigrum; 3.2 Semen Tracchyspermum ammi. 
✗ ✗ 
11 
MON-A11 6.9000 
16.0 EL; 30.0 Angullia angullia; 20.0 Radix Striga 
asiatica; 14.0 Zingiber officinale rhizome; 10.0 Radix 
Smilax myositiflora zingiber; 10.0 Bulbus Allium sativum. 
✓ ✓ 
12 
MON-A12 7.0200 
14.6 EL; 29.3 Honey; 20.5 Bean oil; 2.9 Rhizoma 
Zingiber officinale; 0.4 Flos Eugenia aromatica; 5.9 
Herba piper nigrum; 2.9 Herba Croton caudatum; 4.4 
Herba Coriandrum sativum; 1.5 Herba Nigella sativa; 1.5 
Fructus Pimpinella anisum; 1.5 Stichopus variegatus; 
14.6 Morinda citrifolia. 
✗ ✗ 
13 MON-A13 2.2700 100.0 EL. ✓ ✓ 
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14 
MON-A14 5.0500 
25.6 EL; 25.6 Maca extract/Rhizoma Lipidum meyenii; 
25.6 American Ginseng extract; 23.3 Ginkgo biloba 
powder. 
✗ ✗ 
15 MON-A15 1.5500 100.0 EL. ✓ ✓ 
16 
MON-A16 2.4670 
70.0 EL; 10.0 Radix Achyranthes bindentata; 10.0 Cortex 
Eucommia ulmoides; 10.0 radix Astrogalus 
membranaceus bge. 
✓ ✓ 
17 
MON-A17 8.1090 
51.2 EL; 2.1 Euginia caryaphylata Fructus; 4.3 Radix 
Curcuma zedoaria; 4.3 Zingiber officinale roscope; 2.5 
Rhizome Cuminum cyminum; 2.1 Semen Piper nigrum; 
2.1 Rhizome Alpina galangal; 4.3 Semen Pimpinella 
anisum; 1.3 Semen Cariandrum sativum; 12.0 Semen 
Nigella sativa; 12.0 Cortex Cinnamomum zeylanicum; 1.8 
Fructus Myristica fragrans. 
✗ ✗ 
18 
MON-A18 6.2360 
1.0 EL; 2.0 Piper Longum fructus; 1.0 Helicteres isora 
stem; 96.0 Coriandrum sativum seed. 
✓ ✓ 
19 
MON-A19 4.5000 
10.0 EL; 30.0 Stem Ardisia crispa; 20.0 Stem 
Cinnamoum iners; 20.0 Radix Moringa elliptica; 5.0 
Rhizome Smilax myositiflora; 5.0 Stem  Alyxia 
reinwardtii; 5.0 Stem Alyxia indica; 5.0 Radix 
Freycinetia malaccensis. 
✗ ✗ 
20 
MON-A20 7.1860 
11.3 EL; 17.5 Herba Cynomorium songaricum; 16.3 
Semen Cuscuta chinensis; 12.5 Cortex Eucommia 
ulmoides; 12.5 Radix Panax ginseng; 11.3 Fructus 
Tribulus terrestris; 10.0 Rhizoma Dioscorea opposite; 8.8 
Fructus Lycium barbarum. 
✓ ✓ 
21 
MON-A21 6.8950 
42.9 EL; 28.6 Eleuthercoccus senticosus root extract; 28.6 
Fructus Tribulus terrestris extract. 
✗ ✗ 
22 MON-A22 5.5640 100.0 EL. ✓ ✓ 
23 MON-A23 3.6560 100.0 EL. ✓ ✓ 
24 MON-X01 2.5896 100.0 EL. ✓ ✓ 
25 MON-X02 2.7273 50.0 EL; 50.0 Ginseng. ✓ ✓ 
26 MON-X03 2.1210 100.0 EL. ✓ ✓ 
27 
MON-X04 0.3734 
15.0 EL; 5.0 Extract Miristica fragrans; 10.0 Extract 
Yohimbin; 20.0 Zingiber rhizome; 30.0 Curcuma 
zedoaria;  20.0 Other ingredients. 
✗ ✗ 
28 
MON-X05 0.8069 
40.0 EL; 10.0 Pantrocinum; 10.0 Syngnathoides 
biaculeatus; 10.0 Panax Ginseng radix; 10.0 Yohimbehae; 
10.0 Ganoderma; 10.0 Hypocampus. 
✓ ✓ 
29 MON-X06 2.5567 100.0 EL, flower seeds and herbs. ✗ ✗ 
EL: Eurycoma longifolia  * The ingredient is exactly as stated on the products’ labels 
 
DISCUSSION 
 
The markers are found in the region of low 
molecular weight of approximately 14kDa and 
distinctively to be at the basic site which is often 
being vertically streaked. The marker spots were 
only detected in coomassie and not in silver 
staining. These staining dyes are known to have 
far less sensitivity i.e leading to weak staining or 
even failure of detection when used for detection 
of highly glycosylated proteoglycans (protein-
glycosaminoglycans) or glycoproteins (protein-
oligosaccharides) [28-29]. Additionally this also 
suggested the markers to be glycopeptides based 
on its low molecular weight and its heat stability. 
Many reports linked, though not conclusively, 
the aphrodisiac activity to be glycopeptide in 
nature [22 - 24]. Our attempts to determine their 
identity by LC MS/MS (results not included) 
failed as the protein database available in Mascot 
for E. longifolia was only four proteins, which 
were related to photosynthetic mechanism rather 
than linked to aphrodisiac activity [30]. In any 
case the de novo sequencing done on the 
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significant ions revealed amino acid sequence 
that may aid in primer designs for further work.   
In most cases the markers are the only spots 
detected due to the extraction process requiring 
boiling causing protein denaturation. This has 
been the norm in traditional extraction as well as 
in most modern techniques whereby chips of the 
dried roots been boiled in water for hours to 
yield extracts supposedly having the aphrodisiac 
activity [31]. Nevertheless two dimensional 
electrophoresis of some extracts were shown to 
have other spots present as well for e.g. Mon-
A07 (Fig 2). As the labels of the products do not 
indicate clearly the extraction process utilized 
this observation of having certain products 
showing numerous spots still remains unclear. It 
must be noted that even if the sample size for the 
unapproved products were relatively small due to 
the difficulties in obtaining them, the detection 
of the markers in them is quite admirable. As 
such it is likely the efficacy of these unapproved 
products might match or are better than the 
approved ones. Nevertheless there are still risks 
of other contaminants (fungi or bacteria or heavy 
metals) which are supposed to be strictly 
regulated by NPCB. The reason why most 
unapproved products contain the biomarkers is 
due to the fact that E. longifolia extract can be 
obtained easily with little processing. This was 
demonstrated by the positive results obtained 
with MON-JV1 extracted in our laboratory. 
Spot A appears as the definite marker as it is 
found present in all extracts labeled to contain E. 
longifolia extracts.  Marker A was also noticed 
to be more prominent and conspicuous than spot 
B. Hence we suggested the use of this spot as a 
quality control marker during the testing in batch 
production of these herbal products at the 
manufacturing site.  Agency such as NPCB may 
incorporate this marker apart from the existing 
Eurycomanone in their enforcing activities [32-
33]. The latter has been clearly indicated as not 
being the constituent responsible for the 
aphrodisiac activity. In the wake of many fake E. 
longifolia products with some even been 
adulterated with drugs like sildenafil citrate or 
acetildenafil sold mostly over the internet, a 
thorough testing involving multiple techniques 
with specific markers such as ours is certainly 
required [34]. The surplus in fake products in the 
US market had even the US FDA got concerned 
[35-36]. 
 
 
 
 
CONCLUSION 
 
The increasing number of herbal products 
relevant to aphrodisiac benefits claimed to have 
incorporated E. longifolia extracts is on an 
alarming rise with various scrupulous activities 
detected in similar extend. A thorough and 
specific authentication is warranted using marker 
A detected in two dimensional electrophoresis, a 
subset of proteomics technology.  
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